Integrating pharmacogenetics into society: in search of a model
- 1 September 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 5 (9) , 663-669
- https://doi.org/10.1038/nrg1430
Abstract
There has been considerable scientific, corporate and policy interest in the more effective use of genetics in both drug development and delivery. Pharmacogenetics - the study of the relationship between an individual's genetic makeup and response to medicinal drugs - has attracted global interest, but will it live up to its promise? Looking beyond the hype that has accompanied much of the commentary in the area, the future of pharmacogenetics will depend on how competing interests and options are resolved.Keywords
This publication has 19 references indexed in Scilit:
- Pharmacogenetics in the treatment of breast cancerThe Pharmacogenomics Journal, 2004
- FDA guidance on pharmacogenomics data submissionNature Reviews Drug Discovery, 2003
- Pharmacogenetics in the Laboratory and the ClinicNew England Journal of Medicine, 2003
- New drug approvals for 2002Nature Reviews Drug Discovery, 2003
- Pharmacogenetics and the future of medical practiceBritish Journal of Clinical Pharmacology, 2002
- Ethical perspectives on pharmacogenomic profiling in the drug development processNature Reviews Drug Discovery, 2002
- Maximizing the value of medicines by including pharmacogenetic research in drug development and surveillanceBritish Journal of Clinical Pharmacology, 2002
- Genetic Predictors of Therapeutic Response to ClozapineCNS Drugs, 2002
- The Economics of Gene Therapy and of PharmacogeneticsValue in Health, 2002
- Ethical and legal implications of pharmacogenomicsNature Reviews Genetics, 2001